Literature DB >> 11092461

Influence of the joint treatment with granulocyte colony-stimulating factor and drugs elevating extracellular adenosine on erythropoietic recovery following 5-fluorouracil-induced haematotoxicity in mice.

L Weiterová1, M Hofer, M Pospísil, V Znojil, J Vácha, A Vacek, I Pipalová.   

Abstract

The presented data address the problem of pleiotropic effects of granulocyte colony-stimulating factor (G-CSF) and suggest the ability of drugs increasing the level of extracellular adenosine to activate erythropoiesis when given jointly with G-CSF. To demonstrate these interactions, the effects of the drugs on the recovery from erythropoietic damage induced in mice by a single dose of 5-fluorouracil (5-FU) were investigated. Elevation of extracellular adenosine and thus activation of adenosine receptors was induced by joint administration of dipyridamole (DP), a drug inhibiting the cellular uptake of adenosine, and adenosine monophosphate (AMP), an adenosine prodrug. The drugs were injected in a 4-d treatment regimen starting 2 h after 5-FU injection. Both DP+AMP and G-CSF alone induced only weak effects. However, the combination of the three drugs produced significant elevation of erythrocytes in the peripheral blood which pertained in the posttreatment period. Stimulation of proliferation of erythroid progenitor cells (BFU-E) in femoral bone marrow and increased levels of reticulocytes in the peripheral blood were observed in the course of the 4-d treatment regimen. In addition, significantly decreased mean cell haemoglobin accompanying the elevated numbers of erythrocytes in the combination-treated mice was found. This effect could be interpreted as the result of a sublethal 5-FU-induced damage to erythroid progenitor and precursor cells forced to proliferate intensively by the combination therapy. The observed additivity and synergism of G-CSF with elevated extracellular adenosine in terms of erythropoiesis is an interesting finding with potential implications in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092461     DOI: 10.1034/j.1600-0609.2000.065005310.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  4 in total

1.  Differential expression of uridine phosphorylase in tumors contributes to an improved fluoropyrimidine therapeutic activity.

Authors:  Deliang Cao; Amy Ziemba; James McCabe; Ruilan Yan; Laxiang Wan; Bradford Kim; Michael Gach; Stuart Flynn; Giuseppe Pizzorno
Journal:  Mol Cancer Ther       Date:  2011-09-27       Impact factor: 6.261

2.  Lack of adenosine A3 receptors causes defects in mouse peripheral blood parameters.

Authors:  Michal Hofer; Milan Pospíšil; Ladislav Dušek; Zuzana Hoferová; Denisa Komůrková
Journal:  Purinergic Signal       Date:  2014-04-25       Impact factor: 3.765

Review 3.  The role of adenosine receptor agonists in regulation of hematopoiesis.

Authors:  Michal Hofer; Milan Pospisil; Lenka Weiterova; Zuzana Hoferova
Journal:  Molecules       Date:  2011-01-17       Impact factor: 4.411

4.  Oral Administration of Ren-Shen-Yang-Rong-Tang 'Ninjin'yoeito' Protects Against Hematotoxicity and Induces Immature Erythroid Progenitor Cells in 5-Fluorouracil-induced Anemia.

Authors:  Fumihide Takano; Yasuyuki Ohta; Tomoaki Tanaka; Kenroh Sasaki; Kyoko Kobayashi; Tomoya Takahashi; Nobuo Yahagi; Fumihiko Yoshizaki; Shinji Fushiya; Tomihisa Ohta
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-27       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.